| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.036 | 0.5 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |